The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities
Open accessAbstract
Bacterial resistance is a rapidly escalating threat to public health as our arsenal of effective antibiotics dwindles. Therefore, there is an urgent need for new antibiotics. Drug discovery has historically focused on bacteria growing in planktonic cultures. Many antibiotics were originally developed to target individual bacterial cells, being assessed in vitro against microorganisms in a planktonic mode of life. However, towards the end of the 20th century it became clear that many bacteria live as complex communities called biofilms in their natural habitat, and this includes habitats within a human host. The biofilm mode of life provides advantages to microorganisms, such as enhanced resistance towards environmental stresses, including antibiotic challenge. The community level resistance provided by biofilms is distinct from resistance mechanisms that operate at a cellular level, and cannot be overlooked in the development of novel strategies to combat infectious diseases. The review compares mechanisms of antibiotic resistance at cellular and community levels in the light of past and present antibiotic discovery efforts. Future perspectives on novel strategies for treatment of biofilm-related infectious diseases are explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Flemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866
Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R., & Lappin-Scott, H. M. (1995) · Annual Review of Microbiology · doi:10.1146/annurev.mi.49.100195.003431 · Cited by 4,544
Bioactive Microbial Metabolites: A Personal View
Bérdy, J. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.1 · Cited by 3,170
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Metagenomics: Application of Genomics to Uncultured Microorganisms
Handelsman, J. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.4.669-685.2004 · Cited by 2,441
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Cited by
Bacterial Biofilm Eradication Agents: A Current Review
Verderosa, A. D., Totsika, M., & Fairfull-Smith, K. E. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00824 · Cited by 555
Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases
Oliveira, D., Borges, A., & Simões, M. (2018) · Toxins · doi:10.3390/toxins10060252 · Cited by 485
Zhao, W., Dao, C., Karim, M., Gomez-Chiarri, M., Rowley, D., & Nelson, D. R. (2016) · BMC Microbiology · doi:10.1186/s12866-015-0617-z · Cited by 424
Antimicrobial peptides under clinical investigation
Koo, H. B., & Seo, J. (2019) · Peptide Science · doi:10.1002/pep2.24122 · Cited by 376
Penesyan, A., Paulsen, I. T., Kjelleberg, S., & Gillings, M. R. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00251-2 · Cited by 318
Self-citationNatural Products as a Source for Novel Antibiotics
Moloney, M. G. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.001 · Cited by 308
Xiu, W., Wan, L., Yang, K., Li, X., Yuwen, L., Dong, H., Mou, Y., Yang, D., & Wang, L. (2022) · Nature Communications · doi:10.1038/s41467-022-31479-x · Cited by 288
Wang, X., Biswas, S., Paudyal, N., Pan, H., Li, X., Fang, W., & Yue, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00985 · Cited by 277
Antimicrobial Activity and Resistance: Influencing Factors
Li, J., Xie, S., Ahmed, S., Wang, F., Gu, Y., Zhang, C., Chai, X., Wu, Y., Cai, J., & Cheng, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00364 · Cited by 266
Extracellular DNA in natural environments: features, relevance and applications
Nagler, M., Insam, H., Pietramellara, G., & Ascher-Jenull, J. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9120-4 · Cited by 263
Cremonini, E., Zonaro, E., Donini, M., Lampis, S., Boaretti, M., Dusi, S., Melotti, P., Lleo, M. M., & Vallini, G. (2016) · Microbial Biotechnology · doi:10.1111/1751-7915.12374 · Cited by 261
Sushmitha, T. J., Rajeev, M., Kathirkaman, V., Shivam, S., Rao, T. S., & Pandian, S. K. (2023) · Scientific Reports · doi:10.1038/s41598-023-37851-1 · Cited by 30
Lima, M., Teixeira-Santos, R., Gomes, L. C., Faria, S. I., Valcarcel, J., Vázquez, J. A., Cerqueira, M. A., Pastrana, L., Bourbon, A. I., & Mergulhão, F. J. (2021) · Molecules · doi:10.3390/molecules26144378 · Cited by 30
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
“Finally, emerging observations focused on glycans in the biofilms of bacterial multicellular communities with new perspectives in antibiotics discovery [35].”
Background
Metadata
- Authors
- Penesyan, A., Gillings, M., & Paulsen, I.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2015-03-24
- Volume
- 20
- Issue
- 4
- Pages
- 5286-5298
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2021401450
- Cited by
- 363
- References
- 80
- FWCI
- 14.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.